Ingrid Øra
51 – 60 of 96
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours
(
- Contribution to journal › Article
-
Mark
Absence of Epstein-Barr and Cytomegalovirus Infection in Neuroblastoma Cells by Standard Detection Methodologies.
(
- Contribution to journal › Article
-
Mark
snoRNPs Regulate Telomerase Activity in Neuroblastoma and Are Associated with Poor Prognosis.
(
- Contribution to journal › Article
-
Mark
Acute onset of ovarian dysfunction in young females after start of cancer treatment.
(
- Contribution to journal › Article
- 2012
-
Mark
Stability of PCR Targets for Monitoring Minimal Residual Disease in Neuroblastoma
(
- Contribution to journal › Article
-
Mark
Identification of BIRC6 as a novel intervention target for neuroblastoma therapy
(
- Contribution to journal › Article
-
Mark
Oncogenic activation of FOXR1 by 11q23 intrachromosomal deletion-fusions in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth
(
- Contribution to journal › Article
-
Mark
Copy Number Defects of G1-Cell Cycle Genes in Neuroblastoma are Frequent and Correlate with High Expression of E2F Target Genes and a Poor Prognosis
(
- Contribution to journal › Article
-
Mark
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes
(
- Contribution to journal › Article